Articles On Medadvisor (ASX:MDR)

The MedAdvisor Ltd (ASX: MDR) share price will be one to watch later this week when it returns from its trading halt. Why is Medadvistor in a trading halt? This afternoon the medication management platform provider requested a trading halt...

Medical software group MedAdvisor (ASX: MDR) is prepared to massively dilute current shareholdings to secure the funds for a $49 million acquisition of Adheris LLC. The Melbourne-based company has entered into a binding agreement to acqui...

Shares in ASX-listed MedAdvisor have been placed in a trading halt today with the health-tech venture announcing plans to acquire US-based medication adherence company Adheris for US$34.5 million (AU$49m), while also raising AU$45 million t...

If you’re interested in gaining exposure to the small cap side of the market, I think it could be worth looking for options in the healthcare sector. In this sector there are a number of companies that are benefiting from favourable tailwi...

Medical technology is a broad field covering areas like biotechnology, pharmaceuticals, and information technology. Advancements in medical technology improve the way doctors diagnose and treat patients, leading to better health outcomes....

Fortunes were to be made in ASX health stocks during March and April as investors looked for salvation from the COVID-19 pandemic fears rocking markets. However, once the two biggest health stocks Resmed (ASX:RMD) and CSL (ASX:CSL) are take...

The Australian share market is home to a number of world class healthcare companies such as Ramsay Health Care Limited (ASX: RHC) and Cochlear Limited (ASX: COH). While I believe both companies still have a lot of growth left in them, the...

Right now, I believe that are a number of small cap ASX shares that have the potential to grow into much larger entities in the future. Three small cap shares which I feel would be worth keeping a close eye on are listed below. Here’s why...

Want to know which stocks the fund managers have been putting their money in (and out) of? We’ve been keeping track so you don’t have to. Trading Places is Stockhead’s recap of substantial holder movements among ASX small caps in the last f...

Due to new technologies and favourable industry tailwinds, I think there are a number of small cap ASX healthcare shares which have the potential to grow materially over the next 10 years. Three small cap healthcare shares to add to your w...

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays.   Themes of the week Cochlear’s...

One area of the market that I think is a good place to look for buy and hold options is the small end of the healthcare sector. I think here you’ll find a number of companies that have the potential to grow significantly in the future than...

When it comes to investing in world class healthcare companies, the Australian share market is home to a number of them such as Cochlear Limited (ASX: COH) and Ramsay Health Care Limited (ASX: RHC). While these blue chip shares certainly h...

Shares in MedAdvisor Limited (ASX:MDR), traded up to 10% higher on Monday after the company announced that its telehealth and on-demand home delivery features are now live. The company is a prominent technology partner used by about 60% of...

Global funding for telehealth companies surged in the March quarter as investors jumped on what will clearly be a trend for 2020. A total of $US788m ($1.3bn) was invested into this sector making it the top funded digital health segment in t...

      Working from home was once an office perk. Now, after a month of everyone being forced to do it in a bid to flatten the curve on coronavirus, plenty of people are realising how much they miss the routine of getting up and heading to...

Following the excellent analysis of how volatile March 2020 was for the Dow Jones Industrial Average by Nick Maggiulli from Of Dollars & Data, I decided to take Nick’s methodology and see what it would reveal about the S&P/ASX Emerg...

2020 was looking good for many companies but COVID-19 changed all that. Some have needed capital to keep going and one was sleep apnoea mouthguard maker Somnomed (ASX:SOM). In February, the company reported solid revenue and operating profi...

Digital medication management company MedAdvisor (ASX: MDR) will add a telehealth service to its online platform to help protect Australians from widespread impacts of the coronavirus pandemic. The company will extend the GP Link feature wi...

The MedAdvisor Ltd (ASX: MDR) share price has been on fire on Tuesday morning. At the time of writing the medical technology company’s shares are up 10% to 44 cents. Why is the MedAdvisor share price rocketing higher? Investors have been b...

 ASX-listed MedAdvisor has fast-tracked plans to launch an “Uber” for pharmacy delivery services as part of the company’s response to the COVID-19 crisis.  MedAdvisor (ASX: MDR) shares have soared more than 25% today on the news to close at...

The developer of a home delivery service for prescription medicines hopes to ease the burden placed on pharmacies and assist those most vulnerable to Covid-19. Listed digital medication management company MedAdvisor (ASX: MDR) has fast-tr...

Australian-based MedAdvisor (ASX: MDR) will begin offering home delivery to customers as a way of reducing pharmacy to patient contact in a COVID-19 environment. The company has announced it will proceed with Phase 1 of its service to help...

The Medadvisor Ltd (ASX: MDR) share price has soared today after the digital medication management company announced it was launching a medication delivery service. Medadvisor shares are currently trading up more than 22% at 40 cents. Home...

The arrival of COVID-19 in Australia has led to government restrictions on travel and large social gatherings, leading people to spend more time at home for business, study, work and leisure. Tech stock analysts said it was reasonable to as...

The Medadvisor Ltd (ASX: MDR) share price is surging higher today after the company provided an update on the role it is playing in the coronavirus outbreak. After rocketing as much as 42.86% higher to $0.45 in early afternoon trade, MedAd...

Digital medication management company MedAdvisor (ASX: MDR) has been endorsed by the UK’s National Pharmacy Association (NPA) as the recommended supplier for consumer digital platform solutions and digital adherence programs. Under the endo...

The MedAdvisor Ltd (ASX: MDR) share price is rocketing higher on Tuesday. In morning trade the leading digital medication management company’s shares are up 15.5% to 33.5 cents. Why is the MedAdvisor share price rocketing higher? Investors...

The Medadvisor Ltd (ASX: MDR) share price surged 13.92% higher today after the market reacted very favourably to the company’s half-year FY20 results. What does MedAdvisor do? MedAdvisor is an Australian software systems developer. The com...

The medical technology sector is a fast-growing sector both domestically on the ASX and internationally. Here are 3 ASX med-tech shares that have seen gains of around 5% so far today. Polynovo Ltd (ASX: PNV) PolyNovo develops innovative...

Here’s our fortnightly wrap of all the news driving ASX health stocks. Of the ASX’s 134-odd small cap health stocks, 51 saw their share prices fall, 73 improved and 15 were flat. The top mover was G Medical (ASX:GMV), which has finally begu...

The Medadvisor Ltd (ASX: MDR) share price was one of the best performers on the Australian share market on Thursday. The digital medication management company’s shares rocketed as much as 28% higher at one stage to a record high of 47.5 ce...

A momentary hiatus in US-China economic conflicts sent Wall Street to fresh records as phase one of the long-awaited trade deal was signed last night. The news brought with it some fresh records on our own market down under. The benchmar...

MedAdvisor (MDR) has signed its second U.S. agreement to provide medication education programs for a top 10 global pharmaceutical company The company will perform the first four pilot programs through a group of 4000 U.S. pharmacies $825,0...

Digital medication management company MedAdvisor (ASX: MDR) has signed a second US agreement to provide a series of digital health education programs for a Top 10 global pharmaceutical company. The deal will be executed in conjunction with...

Did the doc say to take one pill twice daily, or two tablets once daily? When it comes to correct medication, it’s easy to get it wrong. Because of misreading instructions, forgetfulness, laziness or nasty side effects Australians aren’t es...

Digital medication company MedAdvisor (ASX: MDR) has further extended its operations within the growing “ePrescribing” market, following a new two-year deal worth around $1 million per year with pharmacy retail group Sigma Healthcare. Sigma...

07 Nov 2019 - MedAdvisor (ASX:MDR), Australia’s leading digital medication management company, has signed a new 2-year agreement with pharmacy retail group, Sigma Healthcare (ASX:S…

Medication management tech company MedAdvisor (ASX:MDR) will begin a same-day medication delivery fulfilment service. The company has partnered with delivery company Kings Transport to ship right to people’s doors on the same day. The servi...

Listed med-tech company MedAdvisor (ASX: MDR) has signed an agreement with one of Australia's leading pharmacies for three years. Chemist Warehouse will partner with MedAdvisor for a period of three years and will see the pharmacy giant t...

Digital medication management company MedAdvisor Ltd (ASX: MDR) last week announced it has raised $17 million by issuing 340 million new shares at an issue price of 5 cents per share. That actually represented an 11% premium to its last pr...

On Stockhead today: the three biggest opportunities for digital transformation in pharma, why it’s time to get excited about cobalt again, the top 10 stocks that doubled (and even tripled) in 24 hours and the stocks investors are shorting r...

The healthcare sector has been perhaps the slowest of all industries to embrace digitisation — and in fewer countries is this more evident than in Australia, where scripts are still written on paper, for example. But new research suggests t...

An $11 million investment from $4.4 billion US healthcare solutions provider HMS has sent shares in medication management tech company MedAdvisor (ASX:MDR) to four-month highs. MedAdvisor told the market this morning it had successfully rai...

Australian digital medication management company MedAdvisor (ASX: MDR) has secured a new cornerstone investor and preferred partner for its US business following an oversubscribed capital raising. The company successfully raised $17 million...

Stockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade. It’s a short, sharp update to help frame the trading day by showing the biggest movers in percentage terms. The market opens at 10am (easte...

On Stockhead today: Aussie investors head over heels with these gas stocks, September’s top 50 miners, Hot Money Monday and commission free trading could be coming to a broker near you. But first:   The week ahead It’s a public holiday toda...

Companies and institutions that provide medical assistance and services, manufactures of medical equipment, engage in clinical trials and development of drugs, are part of the healthcare sector. The Australian government makes significant c...